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Identification of key RNA binding proteins involved in The Enemy at the Gates: Ca2
synaptic plasticity thus whets one’s appetite for know- Entry through TRPM7 Channelsing what RNAs are being regulated. This question seems
critical for developing a more complete understanding and Anoxic Neuronal Death
of the molecular nature of synaptic plasticity and has
begun to be addressed by the development of new
methodologies (Ule et al., 2003 and references therein).
In brain ischemia, gating of postsynaptic glutamateRelating the current work to mammalian neurons will
receptors is thought to initiate Ca2 overload leadingrequire establishing a clearer relationship between the
to excitotoxic neuronal death. In this issue, Aarts andApCPEB and mammalian isoforms of CPEB. One CPEB
colleagues describe a novel mechanism, whereby gat-transcript appears to be brain specific in mice (mCPEB-3),
ing of TRPM7, a Ca2-permeable nonselective cationdiffering from other isoforms in that it harbors an extra
channel, mediates Ca2 overload and demise of an-2500 bp of 3UTR; this transcript encodes an N terminus
oxic neurons.with a small Q-rich domain—50% in the first 30 amino
acids, but then an unimpressive extension in which the
following 130 amino acids have only 10% Q  N, an The term excitotoxicity describes the pathological con-
average content (Theis et al., 2003). Other mCPEB vari- sequences of the overstimulation of glutamate recep-
ants do not clarify this issue. If mammalian CPEB pro- tors (Olney, 1969), which occurs in brain ischemia/
teins do prove capable of forming prion-like switches anoxia, epilepsy, and brain trauma. Excitotoxic events
on the basis of such short Q-rich domains, one wonders may also be involved in several neurodegenerative dis-
how many other proteins might show similar phenome- eases including HIV dementia and Alzheimer’s and Hunt-
non. For example, a number of proteins with Q-rich N ington’s disease (Beal, 1992; Lipton, 1996). Excitotoxi-
termini are implicated in neurologic disorders (e.g., city is due in large part to overstimulation of the
Huntington’s, spinocerebellar ataxia). If the phenome- N-methyl-D-aspartate receptor (NMDA-R), with sus-
non were widespread, one could imagine great expan- tained gating of its associated ion channel, which allows
sion of the current CPEB-dependent switching model inflow of massive amounts of Ca2 and Na in neurons.
for generating synaptic marks. More generally, perhaps Ca2 overload can trigger several downstream lethal
the findings reviewed here will pave the way to demon- reactions, including nitrosative and oxidative stress, mi-
strating, as suggested by Lindquist, that prion-like tochondrial dysfunction, and protease and phospholi-
switches play a number of important roles in mamma- pase activation, which culminate in cell death (Orrenius
lian cells. et al., 2003). It has been recognized that lethal signals
in brain ischemia are not exclusively mediated through
the NMDA-R associated channel. For example, both glu-
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L-type channels have been implicated in the mecha-
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nisms leading to cell death in anoxic/ischemic brain.
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a model of hypoxia (oxygen/glucose deprivation; OGD)
to unveil a new lethal pathway that involves the activa-
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tion of a cation conductance (IOGD), which results in Ca2
overload. IOGD requires the TRPM7 ion channel protein,Dostie, J., Mourelatos, Z., Yang, M., Sharma, A., and Dreyfuss, G.
(2003). RNA 9, 180–186. a member of the TRP (transient receptor potential) cation
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channel superfamily (Harteneck et al., 2000). In OGD, lung, given that cells are equally intolerant to prolonged
reactive oxygen/nitrogen species gate IOGD/TRPM7, which Ca2 overload.
allows Ca2 entry into the neuron. This triggers a vicious The discovery of a new gate leading to neuronal death
loop since Ca2 overload stimulates further radical pro- opens an exciting new spectrum of possibilities for ther-
duction and IOGD/TRPM7 activation. Significantly, this apy of brain hypoxia and potentially other neuropatho-
pathway is unmasked by inhibiting the classical Ca2 logical conditions. While the authors suggest that a fun-
entry routes through the NMDA-R and the L-type chan- damental reason for the apparent failure of AET in
nels. Depletion of TRPM7 by sRNAi protects neurons clinical trials is the unmasking of the newly described
from Ca2 overload and the consequences of prolonged pathway, they recognize that the reasons may be several
anoxia. Surprisingly, TRPM7 seems to be essential in and more complex. Considerable effort has been put
mediating Ca2 overload and cell death, even in the into developing NMDA antagonists to treat brain isch-
absence of the NMDA and L-type channel block, which emia and other disorders where excitotoxicity may be
suggests a central role for this pathway in both excito- involved. However, NMDA activity is essential for normal
toxic and nonexcitoxic neuronal demise. The authors neuronal function. Modern drugs are generally designed
suggest that these findings can explain the failure of to have high affinity and selectivity for their target, espe-
conventional antiexcitotoxic therapy (AET), which has cially those generated generally by high-throughput
been largely based on the use of NMDA antagonists. screening. High-affinity NMDA blockers (i.e., MK-801)
Conventional AET would only block excitotoxicity, but have unacceptable side effects, which largely explain
eventually unmask the predominant pathway for Ca2 the failure of clinical trials. In contrast, more recent ap-
overload, via TRPM7. proaches that use noncompetitive NMDA antagonists,
Aarts and colleagues (2003) provide evidence that IOGD with a fast offrate from the channel (Lipton and Chen,
involves TRPM7 and that activation of TRPM7 is medi- 2004), are more successful and have no major side ef-
ated by ROS. Both excitotoxocity and anoxia can pro- fects. Neuronal demise and neurological dysfunction in
mote radical formation, which would gate TRPM7 and brain ischemia are clearly due to several components.
promote Ca2 overload and radical production. How- Different therapeutic strategies including thrombolysis,
ever, the mechanism whereby ROS can activate TRPM7 AET, and eventually drugs acting on TRPM channels
during anoxia remains unclear. Also, high intracellular may have to be combined to achieve success.
Mg2 levels may negatively regulate the channel dur- Excitotoxic neuronal loss is not due to one mecha-
ing ischemia. nism, but to overlapping death routines, including necro-
Whereas the novel redox regulation of TRPM7 is very sis, apoptosis (Ankarcrona et al., 1995), and, possibly,
intriguing, perhaps of wider impact is the finding that autophagic cell death (Yue et al., 2002). Aarts and col-
suppression of TRPM7 prevents neuronal demise both leagues show that death due to prolonged anoxia is
in the presence and in the absence of NMDA blockade. of a nonapoptotic type. This is not surprising because
This implies that the new pathway is required also for significant amounts of ATP are required to activate the
excitotoxicity. How does this novel pathway change our apoptosome. Even when ATP/ADP ratio is retained, the
current knowledge of brain ischemia and excitotoxicity? bulk requirement for ATP may be insufficient for apopto-
The authors suggest that anoxia would trigger both exci- sis (Leist et al., 1997). Apoptosis contributes to ischemic
totoxicity and IOGD. However, anoxia rapidly suppresses brain damage and brain infarction can be reduced by
synaptic activity and although glutamate is released by treatment with caspase inhibitors, which may block both
both synaptic and nonsynaptic mechanisms, NMDA-R is the proinflammatory response and the execution of a
quickly desensitized. Increasing the duration of anoxia, subset of cell death.
excitotoxicity would become less important, whereas The last very intriguing aspect of the findings pre-
gating of TRPM7 would become the most relevant route sented by Aarts and colleagues is that different death
to promote Ca2 accumulation. The effect of TRPM7
routines can be recruited at different times, and each
suppression in the absence of NMDA channel blockers
may become more or less relevant as the injury prog-
suggests that IOGD may also be relevant in the early resses. Further work is required to determine the relativephases of anoxia to enhance the loop between Ca2
contribution of ion-dependent and -independent deathoverload and radical production. In this respect, IOGD pathways. The identification of a new important routewould not be dissimilar from other receptors/channels,
that promotes cell disruption will help in designing newwhich have been shown to participate in excitotoxicity.
strategies to keep the enemy from the gates.The authors suggest that the new pathway may be more
relevant than excitotoxicy in determining the lethal con-
sequences of anoxia in brain. Nevertheless, experiments
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Lancaster Roadpathway synergize to promote Ca2 overload and radical
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United Kingdomexpressed in nonexcitable tissues, it is tempting to spec-
ulate that it may have a widespread role in mediating
anoxic injury also in tissues such as liver and lung. How- Selected Reading
ever, if TRPM7 were the predominant lethal effector of
anoxia, it would be difficult to explain the high sensitivity Aarts, M., Iihara, K., Li, W., Xiong, Z., Arundine, M., MacDonald, J.F.,
and Tymianski, M. (2003). Cell 115, this issue, 863–877.to anoxia of brain and heart, when compared to liver or
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